These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. NIH guidelines for research involving recombinant DNA molecules. Wilson DJ Account Res; 1993; 3(2-3):177-85. PubMed ID: 11652293 [No Abstract] [Full Text] [Related]
8. National Institutes of Health. Points to consider in the design and submission of human somatic-cell gene therapy protocols. Human Gene Therapy Subcommittee, NIH Recombinant DNA Advisory Committee. Adopted September 29, 1986. Recomb DNA Tech Bull; 1986 Dec; 9(4):221-42. PubMed ID: 3469693 [No Abstract] [Full Text] [Related]
9. Minutes of meetings, 31 Jul 1990 16 Oct 1990. U.S. National Institutes of Health. Recombinant DNA Advisory Committee Hum Gene Ther; 1991; 2(2):177-91. PubMed ID: 11642903 [No Abstract] [Full Text] [Related]
10. The revised "Points to Consider" document. Hum Gene Ther; 1990; 1(1):93-103. PubMed ID: 2081190 [No Abstract] [Full Text] [Related]
11. Debates, divisions, and decisions: recombinant DNA advisory committee (RAC) authorization of the first human gene transfer experiments. Carmen IH Am J Hum Genet; 1992 Feb; 50(2):245-60. PubMed ID: 1734711 [TBL] [Abstract][Full Text] [Related]
12. Recombinant DNA research: proposed actions under the guidelines. U.S. National Institutes of Health Fed Regist; 1997 Aug; 62(161):44387-90. PubMed ID: 11658086 [No Abstract] [Full Text] [Related]
13. Recombinant DNA research; actions under guidelines; notice. U.S. National Institutes of Health Fed Regist; 1990 Sep; 55(177):37565-7. PubMed ID: 11656027 [No Abstract] [Full Text] [Related]
14. Minutes of meeting, 30-31 May 1991. U.S. National Institutes of Health. Recombinant DNA Advisory Committee Hum Gene Ther; 1992 Feb; 3(1):95-121. PubMed ID: 11642989 [No Abstract] [Full Text] [Related]
16. Recombinant DNA research; request for public comment on "Points to consider in the design and submission of human somatic-cell gene therapy protocols. U.S. National Institutes of Health Fed Regist; 1985 Jan; 50(14):2940-5. PubMed ID: 11645541 [No Abstract] [Full Text] [Related]
17. Procedures to be followed for expedited review of single patient protocols -- recommendations of the RAC, March 2, 1993. U.S. National Institutes of Health. Recombinant DNA Advisory Committee Hum Gene Ther; 1993 Jun; 4(3):307. PubMed ID: 11643143 [No Abstract] [Full Text] [Related]
18. Recombinant DNA research: proposed actions under the guidelines; notice. U.S. National Institutes of Health Fed Regist; 1996 Nov; 61(227):59726-42. PubMed ID: 11645326 [No Abstract] [Full Text] [Related]
19. Recombinant DNA Advisory Committee: minutes of meeting, 3 Oct 1988. U.S. National Institutes of Health. Recombinant DNA Advisory Committee Recomb DNA Tech Bull; 1988 Dec; 11(4):155-94. PubMed ID: 11644344 [No Abstract] [Full Text] [Related]
20. Points to consider in the design and submission of human somatic cell gene therapy protocols. Recomb DNA Tech Bull; 1985 Dec; 8(4):181-6. PubMed ID: 3912845 [No Abstract] [Full Text] [Related] [Next] [New Search]